missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ Human ASS1 (aa 1-79) Control Fragment Recombinant Protein
Click to view available options
Quantity:
100 μL
Unit Size:
100µL
Description
Highest antigen sequence indentity to the following orthologs: Mouse (97%), Rat (97%). This recombinant protein control fragment may be used for blocking experiments with the corresponding antibody, PA5-82738 (PA5-82738. In IHC/ICC and WB experiments, we recommend a 100x molar excess of the protein fragment control based on the concentration and the molecular weight. Pre-incubate the antibody-protein control fragment mixture for 30 min at room temperature.
The protein encoded by this gene catalyzes the penultimate step of the arginine biosynthetic pathway. There are approximately 10 to 14 copies of this gene including the pseudogenes scattered across the human genome, among which the one located on chromosome 9 appears to be the only functional gene for argininosuccinate synthetase. Mutations in the chromosome 9 copy of ASS cause citrullinemia. Two transcript variants encoding the same protein have been found for this gene.
Specifications
Specifications
| Accession Number | P00966 |
| Concentration | ≥5.0 mg/mL |
| For Use With (Application) | Blocking Assay, Control |
| Formulation | 1 M urea, PBS with no preservative; pH 7.4 |
| Gene ID (Entrez) | 445 |
| Name | Human ASS1 (aa 1-79) Control Fragment |
| Quantity | 100 μL |
| Regulatory Status | RUO |
| Gene Alias | AA408052; arginino succinate synthetase; argininosuccinate synthase; argininosuccinate synthase 1; argininosuccinate synthetase; argininosuccinate synthetase 1; arginosuccinate synthetase 1; ASS; Ass1; Ass-1; ASSA; citrulline-aspartate ligase; citrulline--aspartate ligase; citrullinemia; CN; CTLN1; fold; mutant arginino succinate synthetase; RP11-618A20.2 |
| Common Name | ASS1 |
| Show More |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction